Showing results (471-480 of 539) with videos related to
Sort By:
Pageof 54
Current Alzheimer Research|December 24, 2013
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's diseaseRichard A Grove, Conn M Harrington, Andreas Mahler, et al.Biorxiv : the Preprint Server for Biology|January 8, 2024
Arousal as a universal embedding for spatiotemporal brain dynamicsRyan V Raut, Zachary P Rosenthal, Xiaodan Wang, et al.Neuroscience and Biobehavioral Reviews|January 19, 2007
Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studiesAnke Sambeth, Arjan Blokland, Catherine J Harmer, et al.Psychopharmacology|July 4, 2012
Effects of mu opioid receptor antagonism on cognition in obese binge-eating individualsSamuel R Chamberlain, Karin Mogg, Brendan P Bradley, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 29, 2010
Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatumPaul C Fletcher, Antonella Napolitano, Andrew Skeggs, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2016
The relationship between mindfulness, pain intensity, pain catastrophizing, depression, and quality of life among cancer survivors living with chronic neuropathic painPatricia A Poulin, Heather C Romanow, Noriyeh Rahbari, et al.Plos One|July 18, 2015
A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major TraumaR Nicole Howie, James L Borke, Zoya Kurago, et al.The International Journal of Neuropsychopharmacology|July 13, 2011
The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjectsPradeep J Nathan, Barry V O'Neill, Karin Mogg, et al.Psychopharmacology|October 25, 2008
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PETJ R Ellis, P J Nathan, V L Villemagne, et al.Environmental Science & Technology|May 27, 2015
Near-Field Characterization of Methane Emission Variability from a Compressor Station Using a Model AircraftBrian J Nathan, Levi M Golston, Anthony S O'Brien, et al.Pageof 54